Abstract
Purpose:
To investigate the effects of paclitaxel associated with lipid nanoemulsions (LDE-PTX) on postoperative scarring in rabbits undergoing trabeculectomy.
Methods:
Thirty-four rabbits that underwent trabeculectomy were allocated to four groups: LDE-PTX/SC (n = 9), treated with LDE-PTX (1.5 mg, intraoperative subconjunctival injection); LDE-PTX/IV (n = 9), treated with LDE-PTX (4 mg/kg per day intravenously) at the end of the surgery and once per week for 3 weeks; MMC (n = 9), treated with intraoperative 0.4 mg/mL mitomycin-C for 3 minutes; and control group (CTL, n = 7), without treatment. Bleb characteristics and IOP were evaluated over 4 weeks. Animals were killed on day 28. Histologic analyses were performed to assess the amount of scarring and toxicity to the conjunctiva and ciliary body.
Results:
Groups were similar with respect to IOP and anterior chamber depth during the 28-day observation period. The LDE-PTX/SC, LDE-PTX/IV, and MMC groups showed greater bleb height than CTL on days 14 and 21 (P < 0.001). The LDE-PTX/SC, LDE-PTX/IV, and MMC groups showed longer bleb survival time than CTL (P < 0.001). The LDE-PTX/SC, LDE-PTX/IV, and MMC groups were equally effective in reducing fibrosis (P < 0.001), number of blood vessels (P < 0.001), and chronic inflammatory cells (P < 0.01) at the surgical site. However, LDE-PTX/SC and LDE-PTX/IV treatments had lower conjunctival (P < 0.001) and ciliary body toxicity (P < 0.01), compared with MMC.
Conclusions:
The LDE-PTX/SC was effective in reducing the scarring process following trabeculectomy to the same extent as MMC, but with considerably less toxicity to the conjunctiva and ciliary body. The LDE-PTX/IV was somewhat less effective than LDE-PTX/SC or MMC, but could have potential as a postoperative adjuvant treatment. Therefore, the LDE-PTX preparation in both administration routes may offer promising options for wound-healing modulation in the surgical treatment of glaucoma.
Trabeculectomy was introduced by Cairns
1 in 1968 and is still the gold standard surgical treatment of glaucoma. The long-term success of this intervention is, however, limited by the closure of the sclerostomy resulting from excessive subconjunctival scarring,
2 which is considered the major cause of trabeculectomy failure. Fibroblastic proliferation, scarring of the trabeculectomy flap, subconjunctival fibrosis, and remodeling of collagen with contraction of tissue in and around the bleb site are the usual postoperative histopathological features that ultimately lead to the sclerostomy closure.
3,4 Subconjunctival antifibrotics, such as mitomycin-C (MMC) and 5-fluorouracil (5-FU), have been used aiming to reduce the formation of scar tissue, by inhibiting fibroblast proliferation, and interfering with many steps of the healing cascade.
2,5–7 Mitomycin-C is more effective compared with 5-FU,
2 and it is currently used in more than 85% of the trabeculectomies.
8 However, severe adverse effects and complications, such as bleb leaks, hypotony and infection may follow the use of MMC.
2,9,10 Thus, the development of alternative therapeutic strategies based on more effective and safer properties are mandatory to warrant a better prognosis after trabeculectomy.
In this regard, paclitaxel (PTX), an anticancer agent belonging to the taxane class, has been shown to enhance the success of trabeculectomy
11–14 due to its capacity of inhibiting the fibroblast migration and scar contraction,
15 similar to MMC.
14,16 However, PTX therapeutic efficacy is limited by the pharmacological instability induced by its physicochemical properties, such as hydrophobicity.
13,14 Lack of a satisfactory carrier for paclitaxel solubilization is a major drawback for the use of this agent as an adjuvant therapy for trabeculectomy. Some carriers, such as polyanhydride disks
12 and Carbopol 980 hydrogel,
16 have been attempted to achieve greater stability of PTX for subconjunctival use. However, none of those PTX formulations was adequate to introduce PTX as a valid alternative as antifibrotic agent. Moreover, the carrier used in commercial PTX formulation for intravenous cancer treatment, Cremophor EL, bears intolerable side effects for ophthalmological use, such as hypersensitive reactions.
17
As previously reported, after intravenous injection, nonprotein lipid nanoparticles termed LDE, that resemble the lipid structure of low-density lipoprotein (LDL), the lipoprotein that contains most of cholesterol in the plasma, can bind to the LDL receptors and concentrate associated drugs in malignant tumors
18–20 or in inflamed tissues as in atherosclerosis,
21,22 rheumatic disease,
23 or grafted organs.
24 This has been shown not only in animal models of disease,
25,26 but also in patients with either solid
18,19 or hematologic tumors.
20,27 In both experimental studies and clinical trials enrolling patients with cancer, PTX and other antineoplastic agents had their toxicity drastically decreased by the association to LDE, without affecting their pharmacological action.
19,20,25–27
Overexpression of LDL receptors is the mechanism that allows the concentration of PTX associated to LDE in the targeted tissues.
19 The need for cholesterol and other lipids for building new membranes during accelerated mitosis rates determines the receptor overexpression in neoplastic and inflammatory tissues.
19,22,23 In fact, LDL receptors are also overexpressed in the activated human tenon fibroblasts,
28 which justifies the use of LDE as a PTX carrier for subconjunctival antiscarring therapy.
This study was designed to test the efficacy and safety of LDE-PTX as an antiscarring agent in rabbits undergoing trabeculectomy. We hypothesized that intraoperative LDE-PTX can be as efficacious, but less toxic, than MMC. Moreover, because systemic LDE-PTX has been shown to be safe for human cancer chemotherapy, we also decided to investigate the intravenous use of LDE-PTX as a possible novel approach in filtration surgery.
Thirty-four male New Zealand White rabbits (provided by USP Medical School Animal Care Unit, São Paulo, Brazil) weighing 3.5 ± 0.4 kg were housed in individual cages in a temperature-controlled room on a 12-hour light/dark cycle; animals were fed ad libitum during the experimental period. All animals underwent trabeculectomy, performed under anesthesia with intramuscular injection of ketamine (50 mg/kg) and xylazine (23 mg/kg). Before the surgical procedure, topical anesthetic eye drop proxymetacaine HCl 0.5% (Anestalcon; Alcon, São Paulo, Brazil) was applied. The rabbits were allocated to four groups, according to the antiscarring treatment:
The study was carried out in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and was approved by the Medical Experimental Research Ethics Committee of the School of Medicine of the University of São Paulo (no. 379/13).
The surgical procedure was performed in all animals by a single surgeon (MLO). A superior 8-0 silk corneal traction suture was placed to allow for infraduction of the globe. After a superior limbal peritomy, a partial-thickness scleral flap (3.0 × 3.5 mm) was created, starting 2.5 mm behind the limbus and continuing until the blade was just visible in the anterior corneal stroma. The anterior chamber was entered using a 45-degree blade. A fragment of tissue containing the inner sclera, trabeculum, and peripheral cornea measuring approximately 2 × 2 mm was excised. A peripheral iridectomy was then performed and the anterior chamber was filled with balanced salt solution. The scleral flap and the conjunctiva were closed with 10-0 nylon sutures. Topical antibiotic with steroid drops and ointment (ciprofloxacin + dexamethasone) were used, once a day, until animals were killed.
After 4 weeks, animals underwent euthanasia by overdose sodium pentobarbital intravenous injection. Right eyes were then enucleated to prepare for histopathologic examination by conventional optical microscopy.
On the day of the surgery and on days 1, 3, 7, 14, 21, and 28 after the surgery, all animals were examined to measure IOP and evaluate the bleb characteristics. The IOP was measured at approximately 9 AM with an applanation tonometer (Tono-Pen Avia; Reichert, Inc., Depew, NY, USA), under topical anesthesia with proxymetacaine HCl 0.5%. The average of five readings was used for the analysis.
A masked observer classified the anterior chamber depth and bleb height. The anterior chamber depth was graded as deep, shallow, or flat; bleb height was graded as high, elevated, shallow, or flat.
35 Bleb survival was taken as the primary efficacy endpoint. Bleb failure was defined when a flat, scarred, vascularized bleb was observed in association with a deep anterior chamber.
Eyes were fixed in formalin for 24 hours and embedded in paraffin; 5-μm sections of the surgical sites were stained with hematoxylin-eosin and with Masson Trichrome. Histological evaluations were conducted by an experienced pathologist, who was masked for the groups.
For assessment of scar formation at the subconjunctival space, the following parameters were evaluated: fibroblast count, fibrosis, collagen organization, collagen density, stromal edema, density of blood vessels, and number of mononuclear cells.
Fibroblasts were graded according to Butler et al.
36 as follows:
absent, without fibroblasts in the tissue;
low count, when involving less than 50% of tissue;
moderate count, when involving between 50% and 80% of tissue; and
high count, when involving ≥80% of the tissue. Stromal edema was scored according to the same scale
36 as follows:
absent, without edema in the tissue;
mild, when involving less than 50% of tissue;
moderate, when involving between 50% and 80% of tissue; and
intense, when involving ≥80% of the tissue. The fibrosis grading scale, according to Koz et al.,
16 was as follows:
negative, if less than 10% of the field was constituted by fibrous tissue;
mild, if between 10% and 25%;
moderate, if between 26% and 75%; and
severe, if more than 75%.
To evaluate collagen organization, the scoring system described by Ekinci et al.
37 was used:
no stromal disorganization, with parallel mature collagen fibers;
weak stromal disorganization, with long and discrete collagen fibers;
moderate stromal disorganization, with shortened and focal perpendicular sequence of collagen fibers; and
strong stromal disorganization, with collagen fibers shortened and ponting in all directions. Subconjunctival collagen density was graded according to Perkins et al.
38:
no alteration, with no stain;
minimal alterations, with light blue stain;
mild alterations, with mild blue stain;
moderate alterations, with fairly blue stain; and
severe alterations, with densely blue stain.
Density of blood vessels in the subconjunctival tissue was graded according to Okuda et al.,
39 with slight modifications:
no blood vessel per image;
1 to 5 blood vessels per image, and
6 to 20 blood vessels per image. Mononuclear cells were counted at 10 high-power fields, and the average number of cells in these zones was analyzed.
For the assessment of conjunctival toxicity, we used the grading system described by Polak et al.,
40 slightly modified by Ekinci et al.
37:
no histologic alteration, normal conjunctival tissue and no inflammation;
minimal histologic alterations, demonstrating thickening of the conjunctiva but preservation of the conjunctival epithelium;
mild histologic alterations, demonstrating thickening of the conjunctiva, conjunctival epithelium preserved, and mild inflammatory cell infiltration;
moderate histologic alterations, demonstrating thickening of the conjunctiva, conjunctival epithelium preserved, mild inflammatory cell infiltration, and loss of collagen fibril organization;
severe histologic alterations, with loss of conjunctival epithelium, total disorganization, and necrosis of the underlying scleral stroma. Goblet cells were counted at 10 high-power fields, and the average number of these cells was analyzed.
For the assessment of ciliary body toxicity, we evaluated three parameters based on the grading system published by Ekinci et al.
37: ciliary epithelium height, vascular congestion (distension of vascular lumens by erythrocytes), and edema (distension of the stromal collagen fibers) in the ciliary body. Alterations in ciliary epithelium height were scored as
minimal decrease,
mild decrease,
moderate decrease, and
severe decrease; whereas the intensity of edema and congestion were scored as
absent,
minimal,
mild,
moderate, and
severe.
Statistical analysis was performed using SPSS 20.0 statistical software (IBM SPSS Statistics, IBM Corporation, Chicago, IL, USA). Survival analysis of the surgery was performed using the Kaplan-Meier curve and the log rank test. The quantitative parameters were analyzed using the Kruskal-Wallis test, followed by Bonferroni correction for multiple analyses. All the semiquantitative parameters were analyzed using the Kruskal-Wallis test, followed by the test for multiple comparisons of Dunn. For all the analyses, P < 0.05 was considered statistically significant.
The authors thank Débora Deus, BSc, for help with the experiments.
Supported by the São Paulo State Research Support Foundation (FAPESP, São Paulo, Brazil) and a Research Carrier Award from the National Council for Scientific and Technological Development (CNPq, Brasilia, Brazil) (RCM).
Disclosure: M.L. Occhiutto, None; F.R. Freitas, None; P.P. Lima, None; R.C. Maranhão, None; V.P. Costa, None